Simplex Trading’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.55K Buy
+590
New +$5.29K ﹤0.01% 7707
2025
Q4
Sell
-1,500
Closed -$13K 9245
2025
Q3
$13K Buy
+1,500
New +$13.2K ﹤0.01% 7701
2025
Q2
Sell
-960
Closed -$10K 9154
2025
Q1
$10K Sell
960
-2,040
-68% -$22K ﹤0.01% 7091
2024
Q4
$30K Sell
3,000
-1,640
-35% -$20.7K ﹤0.01% 6355
2024
Q3
$76K Buy
4,640
+630
+16% +$8.97K ﹤0.01% 5490
2024
Q2
$44K Sell
4,010
-780
-16% -$9.69K ﹤0.01% 6211
2024
Q1
$63K Buy
4,790
+2,340
+96% +$30.4K ﹤0.01% 6053
2023
Q4
$36K Buy
2,450
+2,190
+842% +$26.8K ﹤0.01% 6393
2023
Q3
$3K Sell
260
-6,530
-96% -$126K ﹤0.01% 7901
2023
Q2
$170K Sell
6,790
-2,730
-29% -$45.8K ﹤0.01% 4483
2023
Q1
$141K Buy
9,520
+6,360
+201% +$118K ﹤0.01% 4750
2022
Q4
$44K Buy
3,160
+3,080
+3,850% +$84K ﹤0.01% 6034
2022
Q3
$2K Sell
80
-5,340
-99% -$223K ﹤0.01% 9289
2022
Q2
$188K Buy
5,420
+5,400
+27,000% +$346K ﹤0.01% 4692
2022
Q1
$2K Sell
20
-690
-97% -$79.9K ﹤0.01% 9858
2021
Q4
$67K Sell
710
-490
-41% -$44.1K ﹤0.01% 6828
2021
Q3
$155K Hold
1,200
﹤0.01% 5993
2021
Q2
$147K Buy
1,200
+1,194
+19,900% +$165K ﹤0.01% 6165
2021
Q1
$87K Buy
6
+4
+200% +$679 ﹤0.01% 5934
2020
Q4
$27K Hold
2
﹤0.01% 6748
2020
Q3
$42K Buy
+2
New +$328 ﹤0.01% 5771
2019
Q3
Hold
0
-$2K 7537
2019
Q2
Hold
0
6754
2018
Q4
Sell
-5
Closed -$55K 7372
2018
Q3
$55K Buy
5
+2
+67% +$5.22K ﹤0.01% 5069
2018
Q2
$807K Buy
+3
New +$6.93K ﹤0.01% 1981
2018
Q1
Hold
0
3870
2016
Q1
Hold
0
-$3K 5885
2015
Q4
Hold
0
4235
2015
Q3
Hold
0
1748
2015
Q2
Hold
0
2303

Other funds holding IMUX

Simplex Trading's IMUX Position: Q4 2025 in Review

Simplex Trading sold out of Immunic (IMUX) in Q4 2025, closing a stake of 438 shares — an estimated $3.21K sold.

Simplex Trading first reported a position in IMUX in Q4 2015 and held it in 21 quarters. The position peaked at $124K in Q1 2025. 58 funds tracked by Wall St. Rank hold IMUX as of Q4 2025.

  • Simplex Trading reported no remaining Immunic position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 438 Immunic shares in Q4 2025, an estimated $3.21K.
  • Simplex Trading first reported a position in Immunic in Q4 2015 and held it in 21 quarters.
  • Simplex Trading's Immunic position peaked at $124K in Q1 2025.
  • 58 funds tracked by Wall St. Rank held Immunic as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.